- Viral-associated cancers and disorders
- Pneumocystis jirovecii pneumonia detection and treatment
- HIV/AIDS drug development and treatment
- Lymphoma Diagnosis and Treatment
- Acute Lymphoblastic Leukemia research
- Blood groups and transfusion
- Blood transfusion and management
- Chronic Lymphocytic Leukemia Research
- Neutropenia and Cancer Infections
- Eosinophilic Disorders and Syndromes
- Energy and Environment Impacts
- Hemoglobinopathies and Related Disorders
- Cardiac tumors and thrombi
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Congenital Diaphragmatic Hernia Studies
- Peptidase Inhibition and Analysis
- Venous Thromboembolism Diagnosis and Management
- Research on Leishmaniasis Studies
- Air Quality and Health Impacts
- Ethics in Clinical Research
- Cancer Genomics and Diagnostics
- Kruppel-like factors research
- Pulmonary Hypertension Research and Treatments
- Neonatal Respiratory Health Research
- Palliative Care and End-of-Life Issues
Uganda Cancer Institute
2018-2024
Makerere University
2014-2015
Mulago Hospital
2015
Introduction While there have been several studies examining the understanding and quality of informed consent in clinical trials cancer therapies, is limited empirical research on health practitioners’ experiences process care, especially from low resource settings. This study explored professionals’ perspectives information disclosure during consenting care. Methods A qualitative descriptive approach was used to collect data. Face face interviews were conducted with 10 purposively selected...
Air quality in Kampala, the capital of Uganda, has deteriorated significantly past two decades. We made spot measurements Mpererwe district for airborne particulate matter PM 2.5 (fine particles) and coarse particles. was collected on Teflon-membrane filters analyzed mass, 51 elements, 3 anions, 5 cations. Both fine particle concentrations were above 100 µg/m all samples collected. Markers crustal/soil (e.g., Si Al) most abundant fraction, followed by primary combustion products from biomass...
Data on multiple myeloma (MM) in sub-Sahara Africa is scarce. In Uganda, there a progressively increasing incidence of MM over the years.We performed retrospective study 217 patients with at UCI using purposive sampling method. The objectives were to determine clinical characteristics, treatment outcomes, 5 year overall survival and predictors from 01 January 2008 31 December 2012.There 119 (54.8%) males; mean(SD) age population presentation was 59(12.8) years; 183(84.3%) presented bone...
Persistent pulmonary hypertension of the newborn (PPHN) was described in 1969 by Gersomy and co-workers as persistent foetal circulation. Supra - systemic artery pressures result right to left shunting blood through ductus arteriosus and/or foramen ovale. This results from failure normal adaptation extra uterine life heart/lung system. The incidence is estimated at about 0.1-0.2% live born infants, majority being term or post term. There no race gender related predisposition. Management...
Blood transfusion is life-saving but sometimes also associated with morbidity and mortality. There limited data on mortality in patients transfused whole blood sub-Saharan Africa. We described the 30-day all-cause its factors to inform appropriate clinical intervention research priorities mitigate potential risks. A retrospective study was performed purposively sampled at Uganda Cancer Institute (UCI) Mulago hospital year 2018. Two thousand twelve a median (IQR) age of 39 (28–54) years were...
Mortality benefit of transfusion with leucoreduced whole blood has not been demonstrated in the sub-Saharan Africa (SSA). We compared mortality patients cancer transfused and non-leucoreduced a SSA setting.
Introduction: Splanchnic venous thrombosis (SVT) has varied etiology with Philadelphia-negative myeloproliferative neoplasms (MPNs) being the most frequent underlying prothrombotic factor. Hematological indices often remain within normal range because of portal hypertension and its sequelae, causing diagnostic challenges. The high frequency JAK2 mutation among patients SVT reinforces utility V617F testing.Case report: We report a case 62-year-old black man progressive abdominal swelling...
Abstract Purpose: The optimal chemotherapy regimen for treating HIV associated NHL in low resource settings is unknown. We conducted a retrospective study to compare survival rates, treatment response rates and adverse events patients with treated EPOCH CHOP regimens at the Uganda Cancer Institute.Methods: A of diagnosed lymphoma Institute from 2016 – 2018 was done.Results: One hundred eight 12 were analysed. Patients completing 6 or more cycles 51 (47%) group 8 (67%) (p=0.20). year overall...
Abstract Background: The optimal chemotherapy regimen for treating HIV associated NHL in low resource settings is unknown. We conducted a retrospective study to describe survival rates, treatment response rates and adverse events patients with treated EPOCH CHOP regimens at the Uganda Cancer Institute. Methods : A of diagnosed lymphoma Institute from 2016 – 2018 was done. Results: One hundred eight 12 were analysed. Patients completing 6 or more cycles 51 (47%) group 8 (67%) group. year...
Abstract Background: The optimal chemotherapy regimen for treating HIV associated NHL in low resource settings is unknown. We conducted a retrospective study to describe survival rates, treatment response rates and adverse events patients with treated CHOP dose adjusted-EPOCH regimens at the Uganda Cancer Institute. Methods: A of diagnosed lymphoma Institute from 2016 – 2018 was done. Results: One hundred eight 12 DA-EPOCH were analysed. Patients completing 6 or more cycles 51 (47%) group 8...
Abstract Background: The optimal chemotherapy regimen for treating HIV associated NHL in low resource settings is unknown. We conducted a retrospective study to describe survival rates, treatment response rates and adverse events patients with treated CHOP dose adjusted-EPOCH regimens at the Uganda Cancer Institute. Methods: A of diagnosed lymphoma Institute from 2016 – 2018 was done. Results: One hundred eight 12 DA-EPOCH were analysed. Patients completing 6 or more cycles 51 (47%) group 8...
Abstract Background: The optimal chemotherapy regimen for treating HIV associated NHL in low resource settings is unknown. We conducted a retrospective study to describe survival rates, treatment response rates and adverse events patients with treated CHOP dose adjusted-EPOCH regimens at the Uganda Cancer Institute. Methods: A of diagnosed lymphoma Institute from 2016 – 2018 was done. Results: One hundred eight 12 DA-EPOCH were analysed. Patients completing 6 or more cycles 51 (47%) group 8...